Atrinsic (PTIX) to Release Quarterly Earnings on Monday

Atrinsic (NASDAQ:PTIX) is expected to be posting its resultson Monday, May 11th. Analysts expect Atrinsic to post earnings of ($4.48) per share for the quarter.

Atrinsic Stock Performance

Shares of Atrinsic stock remained flat at $0.80 during midday trading on Monday. The company had a trading volume of 3,350 shares, compared to its average volume of 44,782. The stock’s fifty day moving average is $0.59 and its two-hundred day moving average is $1.15. The stock has a market capitalization of $1.45 million, a price-to-earnings ratio of -0.10 and a beta of 1.13. Atrinsic has a one year low of $0.25 and a one year high of $14.28.

About Atrinsic

Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.